Fig. 4From: Locally advanced breast cancer treated with neoadjuvant chemotherapy and adjuvant radiotherapy: a retrospective cohort analysisOutcomes for patient cohort subdivided by modified-RECIST criteria (MR) grouping. a Locoregional control b) Recurrence-free survival c) Overall survival. MR score 1 and 2 (MR 1 + 2) are grouped together as “non-responders,” MR 3 and 4 (MR 3 + 4) are “partial responders” and MR 5 is “complete response”Back to article page